SCHEMBL30906766

SCHEMBL30906766

CC(C)(O)c1cnc(-c2nc(NC3CCN(S(C)(=O)=O)CC3)ncc2C(F)(F)F)s1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 19/20 0.62
▸ CDK2 P24941 19/20 0.62
▸ CDK1 P06493 12/20 0.62
▸ CCNB1 P14635 12/20 0.62
▸ CCND1 P24385 12/20 0.62
▸ CDK6 Q00534 12/20 0.62
▸ CDK4 P11802 9/20 0.62
▸ CCND3 P30281 9/20 0.62
▸ CCNT1 O60563 3/20 0.53
▸ CDK7 P50613 3/20 0.53
▸ CDK9 P50750 3/20 0.53
▸ CCNH P51946 3/20 0.53
▸ MNAT1 P51948 3/20 0.53
▸ CCNB2 O95067 2/20 0.48
▸ CCNE2 O96020 2/20 0.48
▸ CDK5 Q00535 2/20 0.48
▸ CDK5R1 Q15078 2/20 0.48
▸ CCNB3 Q8WWL7 2/20 0.48
▸ PTK2 Q05397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27213119 1.00 CCNE1 (0.62) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL27213143 0.94 CCNE1 (0.60) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL27213193 0.92 CCNE1 (0.58) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL30906816 0.88 CCNE1 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL27213191 0.88 CCNE1 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL30906856 0.88 CCNE1 (0.63) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL27213159 0.88 CCNE1 (0.63) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL27213219 0.87 CCND3 (0.49) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL27213214 0.87 CDK6 (0.49) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL27213139 0.87 CDK6 (0.49) CCNE1CDK2CDK1CCNB1CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024077216-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS INCORPORATED (US) 2024-04-11 — — WO claimed
WO-2024077216-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS INCORPORATED (US) 2024-04-11 — — WO disclosed
Send feedback